The SG&A Trap

Why Healthcare Staffing's Cost Structure Is the Next Consolidation Driver

Key Takeaways

  • Healthcare staffing's cost structure was built for economics that no longer exist. SG&A levels, headcount models, and operating expense structures designed for a $200-plus bill rate environment and 25 percent gross margins cannot survive at current bill rates and 16 to 18 percent margins. The math does not close, and companies that have not rebuilt their operating models are starting to show it on the balance sheet.

  • The Joint Commission certification count tells the market entry story. About 400 agencies held JC certification in 2020. That number grew to about 1,400 during the pandemic boom. Most of those 1,000 new entrants built cost structures on pandemic economics: recruitment teams, technology platforms, and operational infrastructure sized for a market that no longer exists at those volumes or rates.

  • Consolidation is already underway, and DSO pressure is speeding it up. Cash flow and days-sales-outstanding problems are the near-term forcing function for many mid-market agencies. Companies with capital to wait out the cycle will acquire. The ones without it will exit on unfavorable terms or simply close.

  • This is not a cyclical correction. It is a structural reckoning. The agencies that survive will be the ones that rebuilt their operating model proactively, before the cash crisis forced the issue. Reactive cost-cutting under financial pressure produces a different company than deliberate redesign from a position of stability.


In 2020, about 400 staffing agencies held Joint Commission certification, the standard quality accreditation for healthcare staffing organizations competing for hospital and health system contracts at scale.

At the peak of the pandemic travel nursing boom, that number had grown to about 1,400.

A thousand new entrants, most of them built on pandemic economics: travel nurse bill rates at $200, $220, and higher, and gross margins that made cost structures look sustainable when they were never designed for a normal market. Recruitment teams hired for volume. Technology platforms bought for scale. Operational infrastructure built to process a level of demand that was (hopefully) a once-in-a-generation anomaly.

The pandemic economics are gone, but the cost structures have been left behind.

The Margin Math That Does Not Close

The healthcare staffing industry was not built to run at 16, 17, or 18 percent gross margins. Senior executives who have spent decades in the industry are direct about this: operating expense structures that made sense at 25 percent gross margins become a liability at current rates.

The compression is coming from multiple directions at once. Bill rates have dropped well below pandemic peaks. Agency utilization has declined as health systems improve their internal staffing processes. GPO and VMS fees have gone up, eating into agency margin from the cost side. And the number of agencies competing in the same national and regional pools has grown: the 1,000-plus new entrants who got JC certified during the boom are still in the market, competing for a supply of available travel nurses that has not grown to match.

The result is a market where volume is down, rates are down, fees are up, and competition is broader than it has ever been. That combination is what makes this moment different from previous post-boom cycles in healthcare staffing.

The DSO Forcing Function

The near-term mechanism driving consolidation is not gross margin alone. It is cash flow.

Healthcare staffing agencies operate on a float: they pay clinicians weekly and collect from health systems on 60, 75, or 90-day terms. That float requires working capital. When volume drops and margins compress, the working capital requirement does not shrink to match. It grows as a share of a smaller revenue base. At the same time, many health systems have stretched their own payment terms further as their financial pressures have grown.

Days-sales-outstanding pressure is starting to surface in conversations about mid-market agency financial health. Companies that built their working capital models on pandemic revenue levels are now managing a real mismatch between their operating cash needs and what their lenders will extend, as those lenders reevaluate their own exposure to the sector.

This is the near-term mechanism for market exit. It moves fast. When a company runs out of working capital, the exit is quick and the terms are poor.

Two Ways to Navigate the Reckoning

There are two fundamentally different ways a healthcare staffing company can respond to the current cost environment.

The first is reactive: cut headcount when cash flow forces it, reduce marketing and technology spend to preserve liquidity, delay infrastructure investment, and hope the market recovers before the balance sheet runs out. This approach keeps the current organizational design while weakening it. The company that comes out of a reactive cost-cutting process is smaller, not fundamentally different, and it has lost the talent and infrastructure it will need to compete once the market normalizes.

The second is deliberate: rebuild the operating model proactively, from a position of relative financial stability, before the crisis forces the issue. That means making hard calls about the cost structure that pandemic economics justified and current economics do not, on recruitment model efficiency, technology stack rationalization, and the organizational design that fits the market that exists now, not the one that existed in 2021.

The companies taking the second approach are identifiable. They are making leadership changes that reflect a clear-eyed view of what the next five years require. They are investing in the capabilities, enterprise sales, integration, and consulting depth that survive the consolidation wave rather than the ones that drove revenue during the boom. They are recruiting executives from outside the traditional healthcare staffing talent pool because they recognize the old playbook does not work in the new market.

The SG&A Trap is a choice between two futures, and it closes faster than most companies expect. The time to redesign is before cash flow pressure makes the decision for you.


Morgan Taylor Executive Search works with healthcare staffing leadership teams making deliberate decisions about their organizational design for the next market cycle, not reacting to the current one. If that conversation is relevant to where your company is right now, we should talk.

Next
Next

The Advisor's Paradox